期刊文献+

自拟补肝益肾活血汤联合甲氨蝶呤治疗老年类风湿关节炎的效果观察

Effects of self-made Bugan Yishen Huoxue decoction combined with methotrexate in the treatment of elderly rheumatoid arthritis
下载PDF
导出
摘要 目的观察自拟补肝益肾活血汤联合甲氨蝶呤治疗老年类风湿关节炎(rheumatoid arthritis,RA)的效果。方法选取本院2016年9月至2019年9月接诊的60例RA老年患者,按随机数字表法分为观察组与对照组,各30例。对照组给予甲氨蝶呤片西药治疗,观察组在对照组基础上给予本院自拟补肝益肾活血汤治疗。治疗4个月后,比较两组患者临床治疗指标[视觉模拟评分(VAS)、健康评估问卷调查(HAQ)、疾病活动度评分(DAS28)];于治疗前、治疗4个月后,记录血常规指标[血红蛋白(Hb)、血小板(PLT)]及炎症因子指标[C反应蛋白(CRP)、肿瘤坏死因子-α(TNF-α)]、血清类风湿因子(RF)水平变化。结果治疗4个月后,观察组患者VAS、HAQ、DAS28评分均低于对照组(P<0.05);治疗4个月后,两组患者Hb水平均较治疗前升高,且观察组高于对照组(P<0.05),两组患者PLT、各炎症因子、RF水平均低于治疗前,且观察组均低于对照组(P<0.05)。结论自拟补肝益肾活血汤联合甲氨蝶呤治疗老年类风湿关节炎具有较好的临床疗效,能改善患者的贫血状态,减轻炎症反应,有利于预后康复。 Objective To observe the therapeutic effects of self-made Bugan Yishen Huoxue decoction combined with methotrexate on elderly rheumatoid arthritis(RA).Methods 60 elderly RA patients who were admitted to the hospital from September 2016 to September 2019 were selected and they were divided into observation group and control group according to the random number table method,with 30 cases in each group.Control group was given Western medicine methotrexate tablets,and observation group was treated with self-made Bugan Yishen Huoxue decoction based on control group.After 4 months of treatment,the clinical treatment outcomes indicators[visual analogue score(VAS),health assessment questionnaire(HAQ),disease activity score 28(DAS28)]were compared between the two groups.Before treatment and after 4 months of treatment,the routine blood indicators[hemoglobin(Hb),platelets(PLT)],inflammatory factors[C reactive protein(CRP),tumor necrosis factor-α(TNF-α)]and rheumatoid factor(RF)were recorded.Results After 4 months of treatment,the scores of VAS,HAQ,and DAS28 in observation group were lower than those in control group(P<0.05).After 4 months of treatment,the Hb levels in the two groups of patients were higher than those before treatment,and the level in observation group was higher than that in control group(P<0.05).The levels of PLT,inflammatory factors,and RF of the two groups were lower than those before treatment,and the levels in observation group were lower than those in control group(P<0.05).Conclusion Self-made Bugan Yishen Huoxue decoction combined with methotrexate has a good clinical efficacy,and can improve the anemia status and relieve the inflammatory response of elderly RA patients,and it is beneficial to the prognosis and rehabilitation.
作者 余跃 Yu Yue(Department of Rheumatology and Immunology,Jiujiang University Affiliated Hospital,Jiujiang,Jiangxi,332000,China)
出处 《当代医学》 2020年第32期80-82,共3页 Contemporary Medicine
关键词 补肝益肾活血汤 类风湿关节炎 炎症因子 Bugan Yishen Huoxue decoction Rheumatoid arthritis Inflammatory factors
  • 相关文献

参考文献8

二级参考文献93

  • 1杜桂芹,程欣弘,常曼丽,王秀云.下肢静脉曲张患者的血流变及血脂分析[J].中国血液流变学杂志,2004,14(2):263-264. 被引量:5
  • 2中华人民共和国卫生部.中药新药临床研究指导原则[M].北京:中国医药科技出版社,2002.115-119.
  • 3国家中医药管理局.中医病证诊断疗效标准[M].南京:南京大学出版社,2000.79.
  • 4国家食品药品监督管理局.中药新药临床研究指导原则(试行)[M].北京:中国医药科技出版社,2002:208.
  • 5Choy EH, Panayi GS. Cytokine pathways and joint inflammation in rheumatoid arthritis [ J ]. N Engl J Med, 2001, 344 (12) : 907 -916.
  • 6Ciu E, Gabay C, Finckh A. Joint damage progression in patients with rheumatoid arthritis in clinical remission. Do biologies perform better than synthetic antirheumatic drugs [ J] .9 J Rheumatol, 2014, 41(8) : 1576 -1582.
  • 7Morgan CL, Emery P, Porer D, et al. Treatment of rheumatoid arthritis with etanercept with reference to disease-modifying anti-rheumatic drugs: long-term safety and survival using prospective, observational data[ J]. Rheumatolagy( Oxford), 2014, 53 ( 1 ) : 186 - 194.
  • 8Koike T, Harigai M, Inokuma S. Safety and effectiveness of 6 months' etanercept monotherapy and combination therapy in Japanese patients with rheumatoid arthritis: effect of concomitant disease-modifying antirheumatic drugs [ J ]. J Rheumatol, 2013, 40 ( 10 ) : 1658 - 1668.
  • 9Oladapo A, Barner JC, Lawson KA, et al. Medication effectiveness with the use of tumor necrosis factor inhibitors among Texas medicaid patients diagnosed with rheumatoid arthritis [ J ]. J Manag Care Pharm, 2014, 20(7) : 657 -667.
  • 10Hyrich K, Lunt M, Watson KD, et al. Outcomes after switching from one anti-tumor necrosis factor alpha agent to a second anti-tumor necrosis factor alpha agent in patients with rheumatoid arthritis: results from a large UK national cohort study[ J]. Arthritis Rheum, 2007, 56(1) : 13 -20.

共引文献1368

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部